Skip to main content

Newsfeed

Alzheimer's Disease, Dementia & Cognitive Disorders
Biogen Inc revived plans on Tuesday to seek U.S. approval for Alzheimer's treatment aducanumab, surprising investors and saying data from more patients in two discontinued studies showed the drug reduced the decline of patients.
Newsfeed
By Madeline Kennedy(Reuters Health) - Many sleep apnea patients may have impaired attention and decision-making ability, even if they are being treated with continuous positive airway pressure (CPAP), a small study suggests.
Schizophrenia & Psychotic Disorders
Sophisticated research methods are yielding insights into the pathogenesis of schizophrenia, according to two recent studies.
Newsfeed
By Lisa Rapaport(Reuters Health) - The appeal of smoking for children and teens may be tied at least in part to their race or ethnicity, a recent U.S. study suggests.
Schizophrenia & Psychotic Disorders
Injectable aripiprazole lauroxil is equally effective in adults with schizophrenia regardless of age or gender, a new post-hoc analysis shows.
Newsfeed
By Will Boggs MDNEW YORK (Reuters Health) - Nocturnal hot flashes and sleep disturbance independently contributed to depression in women with artificially-induced estrogen deprivation, researchers report.
Schizophrenia & Psychotic Disorders
A probabilistic model that combines history, clinical assessment, and fatty-acid biomarkers accurately predicts the transition from ultrahigh risk to first-episode psychosis, researchers have found.
Newsfeed
By Kathryn Doyle(Reuters Health) - Obstructive sleep apnea is linked with an increased risk of developing type 2 diabetes, new research shows.
Newsfeed
By Madeline Kennedy (Reuters Health) - Health might be its own reward, but even cash incentives only work in the short term to motivate people to exercise more and activity trackers add little benefit, according to a study from Singapore. "Readers…
Newsfeed
Bowing to public pressure, the U.S. Drug Enforcement Administration (DEA) said on Thursday it had delayed a decision on whether to classify the botanical substance kratom, which is available online in the United States as a dietary supplement, as a…
Back to Top